Solitary Premature Sebaceous Hyperplasia Associated with Acneiform Eruption
نویسندگان
چکیده
منابع مشابه
Sorafenib-Associated Facial Acneiform Eruption
INTRODUCTION Sorafenib is an oral multikinase inhibitor that targets tumor cell angiogenesis and proliferation. Drug-associated cutaneous adverse events, such as alopecia and hand-foot skin reaction, occur frequently. Sorafenib-related side effects affecting hair, nails, and skin are summarized and the characteristics of sorafenib-treated patients who developed acneiform facial lesions are revi...
متن کاملErratum to: Sorafenib-Associated Facial Acneiform Eruption
The author of the above-mentioned paper noticed some errors subsequent to publication and would like to make the following correction. On page 6 there is to be a change to the labelling of Table 2 footnotes. ''Table 2 Characteristics of patients with sorafenib-associated facial acneiform facial eruptions'' is to be replaced with the following: Open Access. This article is distributed under the ...
متن کاملAcneiform eruption induced by cetuximab.
Cetuximab is a recombinant human/mouse chimeric monoclonal antibody that targets the extracellular domain of the epidermal growth factor receptor (EGFR). Cetuximab is approved by the US Food and Drug Administration for the treatment of EGFR-expressing metastatic colorectal cancer as monotherapy in patients who are intolerant to irinotecan-based chemotherapy, or in combination with irinotecan in...
متن کاملPigmented trichoblastoma with sebaceous hyperplasia.
Trichoblastoma is a rare benign trichogenic tumour with epithelial and mesenchymal components recapitulating the germinal hair bulb and associated mesenchyme. A 50- year- old male patient presented with slowly enlarging circumscribed solid nodule measuring 4x3x4.5 cm over the tip of the nose. Microscopy of tumour revealed nodular tumour spanning the entire dermis with collection of mesenchymal ...
متن کاملSevere Acneiform Eruption Induced by Cetuximab (Erbitux®)
Epidermal growth factor has an important role in the regulation of proliferation and differentiation in epidermal keratinocytes, as well as in the survival, angiogenesis and metastasis of cancer cells. Cetuximab is a chimeric monoclonal antibody selective for the epidermal growth factor receptor that induces a broad range of cellular responses that enhance tumor sensitivity to radiotherapy and ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Acta Dermato-Venereologica
سال: 2004
ISSN: 0001-5555
DOI: 10.1080/00015550410015049